Mach7 Technologies Ltd. · ASX:M7T

Mach7 Technologies — Investor Presentation (October 2016)

17 slides from Mach7 Technologies's investor presentation, Oct 12, 2016

  1. Slide 1: Company Update - ASX Announcement

    ASX Announcement 12 October 2016 For personal use only COMPANY UPDATE Melbourne, Australia: Mach7 Technologies Limited (Mach7 or the Company) (ASX: M7T), a leader in the global enterprise imaging market, is pleased to release a new investor presentation which is attached to this announcement. The pr

  2. Slide 2: Mach7 Technologies Investor Presentation

    For personal use only MACH7 TECHNOLOGIES INVESTOR PRESENTATION, M7T.ASX OCTOBER 2016 Copyright © 2013 Mach7 Technologies Copyright © 2013 Mach7 Technologies

  3. Slide 3: Investment Highlights

    INVESTMENT HIGHLIGHTS Mach7 Technologies is a revenue stage company with a rapidly expanding global customer base For personal use only  Significant first mover advantage in managing digital medical images with proprietary platform already handling >1 billion images  Valuable 100%-owned IP portfol

  4. Slide 4: Company Overview

    COMPANY OVERVIEW Mach7’s merger with 3D Medical created a scalable technology company For personal use only Financial information ($A) Share price (Acs) Post completion of merger with 3D Medical 10 Share price (7-Oct-16) $0.051 8 1 Number of shares (m)1,2,3 954.4 Market Capitalisation $48.7m 6 3 4 2

  5. Slide 5: Board and Management

    BOARD AND MANAGEMENT Strong founder involvement with proven Board and management team For personal use only Board Management Damien Lim Dr Nigel Finch Albert Liong Jenni Pilcher Non-Executive Chairman Non-Executive Director Managing Director and CEO Global CFO and CEO, Australia Operations  21+ yea

  6. Slide 6: Key FY16 Financials

    KEY FY16 FINANCIALS Pro-forma financials demonstrate strong traction For personal use only FY16 FY16 Profit & loss (pro-forma)  Pro-forma revenue was A$5.8m, which reflects what the group would (US$) (A$) Revenue $4.2m $5.8m have earned if the acquisition of Mach7 Enterprise Imaging Platform Cost o

  7. Slide 7: The Problem

    THE PROBLEM Lack of interoperability of current systems prevents optimal patient care outcomes and increases healthcare costs For personal use only Current market state Problems with current Electronic Health Record Systems1  Picture Archiving Communication Systems (PACS) and Vendor Neutral Archive

  8. Slide 8: The Solution

    THE SOLUTION Mach7 Enterprise Imaging Platform is a flexible and scalable solution that allows images and data to be easily shared, improving workflows and patient care outcomes For personal use only  Mach7 Enterprise Imaging Platform is best-in- class software Physician &  Platform simplifies the

  9. Slide 9: Sales Execution

    SALES EXECUTION Clear market demand with recent strategic initiatives driving more consistent cash flows in line with long term strategy For personal use only  Growing service and annual revenue demonstrating clear product-market fit  Increasing number of subscription and pay-per-use contracts dri

  10. Slide 10: Sales Cycle

    SALES CYCLE Mach7 is shortening the sales cycle while winning 86% of bids at the vendor selection stage For personal use only Via increased investment in Mach7 is reducing the cost and time marketing and brand-to-solution to sale through a combination of recognition, relationship management is expec

  11. Slide 11: Customer Evolution

    CUSTOMER EVOLUTION Mach7’s global customer base is progressing from earlier adopters towards significantly larger mid-market For personal use only 499 Installed sites, across… 11 Countries 46 Unique customers, comprising… 33 Hospital 8 Imaging centres 5 Others (eg. Telstra) Early customers – academi

  12. Slide 12: Technology and Intellectual Property

    TECHNOLOGY AND INTELLECTUAL PROPERTY Mach7’s 100%-owned proprietary technology supports a scalable platform managing >1 billion medical images For personal use only Mach7 Enterprise Imaging Platform Intellectual property portfolio Proprietary digital image management system Mach7 gives access to a p

  13. Slide 13: Market Opportunity

    MARKET OPPORTUNITY Mach7 has a US$3.8 billion+ addressable market with the ability to compete across numerous market segments For personal use only Mach7 market opportunity Conversion to an enterprise imaging based platform Healthcare providers are increasingly converting to VNA platforms, as Initia

  14. Slide 14: Industry Leader

    INDUSTRY LEADER Since its launch in 2012, Mach7 is recognised with various industry awards and accolades For personal use only Mach7 “Our PACS vendors all “Mach7 has been a cost effective solution for proposed schemes to Broward… We have better control of the data improve workflow and at a lower cos

  15. Slide 15: Growth Drivers

    GROWTH DRIVERS Mid-market penetration and ongoing product development will drive near term growth For personal use only Shift towards  Increased usage of vendor neutral technology expected to see double digit growth in medical platform image management over the next two years in the US technology 

  16. Slide 16: Strategic Vision

    STRATEGIC VISION Long term strategy focused on building an innovative and industry leading digital health technology company For personal use only Technology and Market share growth Cloud based solutions intellectual property Focus on increasing market share in Entry into cloud based solutions Conti

  17. Slide 17: Disclaimer

    DISCLAIMER For personal use only Summary of information: This presentation contains general and background information about Mach7 Technologies Limited (“M7T”) activities current as at the date of the presentation and should not be considered to be comprehensive or to comprise all the information th

Mach7 Technologies — Investor Presentation (October 2016) on 6ix